Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 700 of 994 entries
View as:

An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc)

Phase: N/A Priority: Normal
NCT ID: NCT05626751 Org: User:
Start: 11/04/22 End: 02/24/25 Due: 02/24/26

Study to Evaluate Darbepoetin Alfa in Pediatric Subjects With Anemia Due to Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT01428154 Org: User:
Start: 04/30/16 End: 11/30/16 Due: 11/30/17

A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 623 in Subjects With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT02411136 Org: User:
Start: 05/31/05 End: 10/31/07 Due: 10/31/08

Effects of Long-term Dosing of AMG 531 on Bone Marrow Morphology

Phase: N/A Priority: Normal
NCT ID: NCT00861224 Org: User:
Start: 08/31/05 End: 05/31/07 Due: 05/31/08

Rheumatoid Arthritis DMARD Intervention and UtilizationStudy

Phase: N/A Priority: Normal
NCT ID: NCT00116727 Org: User:
Start: 10/31/02 End: 10/31/08 Due: 10/31/09

A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01980589 Org: User:
Start: 08/31/13 End: 03/31/16 Due: 03/31/17

ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT00379899 Org: User:
Start: 09/30/06 End: 11/30/09 Due: 11/30/10

Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone

Phase: N/A Priority: Normal
NCT ID: NCT00396279 Org: User:
Start: 07/10/06 End: 02/01/11 Due: 02/01/12

Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01386866 Org: User:
Start: 05/31/09 End: 12/31/10 Due: 12/31/11

A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia Purpura

Phase: N/A Priority: Normal
NCT ID: NCT01071954 Org: User:
Start: 12/30/09 End: 01/12/17 Due: 01/12/18

A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache

Phase: N/A Priority: Normal
NCT ID: NCT03971071 Org: User:
Start: 10/07/19 End: 06/13/23 Due: 06/13/24

Oprozomib and Dexamethasone,in Combination With Lenalidomide or Oral Cyclophosphamide to Treat Newly Diagnosed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01881789 Org: User:
Start: 10/28/13 End: 09/23/19 Due: 09/23/20

A Study of the Absorption, Metabolism, and Excretion of [14C]-AMG 510 Following a Single Oral Dose in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05578859 Org: User:
Start: 03/11/20 End: 03/24/20 Due: 03/24/21

Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant

Phase: N/A Priority: Normal
NCT ID: NCT04087720 Org: User:
Start: 09/09/19 End: 09/07/21 Due: 09/07/22

16.0040 Ankylosing Spondylitis Study

Phase: N/A Priority: Normal
NCT ID: NCT00356356 Org: User:
Start: 04/30/02 End: 09/30/06 Due: 09/30/07

ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00261313 Org: User:
Start: 12/31/05 End: 12/31/07 Due: 12/31/08

Study to Evaluate the Drug-drug Interaction Effect of Omeprazole on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05581992 Org: User:
Start: 01/06/20 End: 01/26/20 Due: 01/26/21

A Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects With Rheumatoid Arthritis Partially Responsive to Methotrexate Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01242917 Org: User:
Start: 09/30/10 End: 07/31/11 Due: 07/31/12

Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis

Phase: N/A Priority: Normal
NCT ID: NCT01744782 Org: User:
Start: 12/20/12 End: 12/13/16 Due: 12/13/17

AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00719550 Org: User:
Start: 02/28/09 End: 06/30/13 Due: 06/30/14

A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT05565560 Org: User:
Start: 01/25/23 End: 09/06/26 Due: 09/06/27

P3 Study to Evaluate Efficacy and Safety of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic Purpura

Phase: N/A Priority: Normal
NCT ID: NCT00603642 Org: User:
Start: 10/01/07 End: 04/13/09 Due: 04/13/10

Study of South African Dialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01890577 Org: User:
Start: 04/30/13 End: 01/31/14 Due: 01/31/15

Study to Evaluate the Safety, Tolerability, and Action of AMG 357 in Females With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02499315 Org: User:
Start: 04/30/15 End: 02/29/16 Due: 02/28/17

Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00604682 Org: User:
Start: 01/01/05 End: 12/01/05 Due: 12/01/06